直肠癌壁外血管侵犯影像学及相关病理学研究进展

Advances in imaging and pathological research on extramural vascular invasion of rectal cancer

  • 摘要: 壁外血管侵犯(EMVI)是指胃肠道肿瘤所在肠管固有肌层外的血管腔内出现肿瘤浸润。MRI检查发现直肠壁外血管管腔异常扩张,形态不规则,且其内流空信号为肿瘤组织信号所代替即可诊断EMVI。以病理学为金标准,对于血管直径>3 mm的EMVI,高分辨MRI检查诊断EMVI的敏感度和特异度高达100%和89%。病理学及高分辨MRI检查所诊断的EMVI与直肠癌局部复发,远处转移以及肿瘤相关死亡具有显著相关性,并被证实为无瘤生存时间及总生存时间的独立性预测因子。EMVI作为直肠癌影像学危险度分层指标之一,被应用于筛选适合术前新辅助放化疗的高风险直肠癌。而且,高分辨率MRI检查诊断EMVI被证实为预测直肠癌新辅助放化疗效果的独立相关因素。类似于高分辨MRI检查肿瘤退缩分级,EMVI经新辅助放化疗后的变化同样可以应用肿瘤退缩分级方法进行评价。

     

    Abstract: Extramural vascular invasion (EMVI) was defined as the presence of tumor cells within an endotheliumlined vessel beyond the muscularis propria. high-resolution MRI had 100% sensitivity and 89% specificity in identification of large (caliber greater than 3 mm) EMVI with histopathology as reference. EMVI detected by both histopathology and MRI was significantly associated with local recurrence, distance metastasis and tumorrelated death in rectal cancer, which was also identified as an independent prognostic factor for 3year tumorfree survival and overall survival. EMVI could be used as one of the risk factors, which would allow stratification of patients with rectal cancer to receive neoadjuvant chemoradiotherapy (neoCRT). Moreover, EMVI detected by high-resolution MRI was identified as an independent predictor for response to neoCRT. Tumor regression grading scale defined by high-resolution MRI could be used to evaluate EMVI regression after neoCRT.

     

/

返回文章
返回